B Cell Activation on an Antigen-Coated Coverslip
JoVE Encyclopedia of Experiments
Immunology
0 views • 2:41 min • July 8th, 2025
Loading...
Overview
This article demonstrates an in vitro protocol for studying organelle dynamics in B cells during immune synapse formation. The method focuses on the sequence of events following antigen recognition by B cell receptors (BCRs), including cytoskeletal remodeling, immune synapse formation, lysosome movement, antigen internalization, and antigen presentation on MHC class II molecules.
Key Study Components
Area of Science
- Immunology
- Cell Biology
- Microscopy-based Cell Analysis
Background
- B cell activation is initiated by antigen recognition via BCRs.
- Immune synapse formation is critical for effective antigen processing and presentation.
- Cytoskeletal remodeling and organelle repositioning are essential for antigen internalization.
- Understanding these processes provides insight into adaptive immune responses.
Purpose of Study
- To visualize and analyze the dynamics of organelles, particularly lysosomes, during B cell immune synapse formation.
- To establish a reproducible in vitro system for studying B cell activation mechanisms.
- To detail the steps leading from antigen recognition to antigen presentation in B cells.
Methods Used
- Preparation of antigen-coated coverslips using anti-BCR and B220 antibodies in PBS.
- Immobilization of antigens and antibodies on coverslips via electrostatic interactions with a polymeric substrate.
- Incubation of B cells on coated coverslips to induce immune synapse formation.
- Observation of cytoskeletal remodeling, organelle movement, and antigen internalization at various time points.
Main Results
- B cells adhere to antigen-coated coverslips via CD45R-antibody interactions.
- BCR engagement with antigen triggers immune synapse formation and cytoskeletal changes.
- Centrosome and lysosome repositioning toward the synapse facilitates antigen internalization.
- Internalized antigens are processed and presented on MHC class II molecules on activated B cells.
Conclusions
- The described protocol enables detailed study of organelle dynamics during B cell activation.
- Immune synapse formation involves coordinated cytoskeletal and organelle rearrangements.
- This system provides a valuable platform for dissecting molecular mechanisms of antigen processing and presentation in B cells.
Frequently Asked Questions
What is the main purpose of this protocol?
The protocol is designed to study the dynamics of organelles, especially lysosomes, during B cell immune synapse formation and activation in vitro.
How are antigens and antibodies immobilized on the coverslip?
Antigens and anti-CD45R antibodies are immobilized on a polymer-coated coverslip via electrostatic interactions between negatively-charged proteins and positively-charged polymers.
What triggers immune synapse formation in B cells?
Immune synapse formation is triggered by the interaction of B cell receptors (BCRs) with immobilized antigens on the coverslip.
How is antigen internalization achieved in this system?
Following synapse formation and cytoskeletal remodeling, lysosomes move toward the synapse, fuse with the membrane, and facilitate internalization of antigen-BCR complexes.
What happens to antigens after internalization?
Internalized antigens are processed into peptide fragments, loaded onto MHC class II molecules, and presented on the surface of activated B cells.
What are the key steps in preparing the antigen-coated coverslips?
Antigen solution is prepared with anti-BCR and B220 in PBS, applied to coverslips, incubated overnight at 4°C, washed, and dried before adding B cells.
Why is this in vitro system valuable for immunology research?
It allows controlled observation and analysis of the cellular and molecular events underlying B cell activation and antigen presentation, facilitating mechanistic studies.
Executive Industry Relevance
In vitro B cell activation on antigen-coated coverslips enables precise dissection of immune synapse formation and organelle dynamics, supporting early-stage immunology discovery. This system provides mechanistic clarity for antigen processing and presentation, informing target validation and de-risking in immunotherapeutic development. The approach enhances predictive confidence for downstream screening and translational research in adaptive immunity.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of B cell receptor signaling and immune synapse formation for functional target validation.
- Clarifies cytoskeletal and organelle remodeling mechanisms, reducing biological ambiguity in early discovery.
- Supports predictive confidence in antigen processing pathways relevant to immunotherapy targets.
Screening & Assay Development
- Establishes a reproducible in vitro system for standardized B cell activation assays.
- Facilitates quantitative measurement of antigen internalization and presentation for assay development.
- Prepares validated biological systems for downstream compound or antibody screening workflows.
Translational & Preclinical Research
- Aligns in vitro findings with disease-relevant immune mechanisms for translational continuity.
- Supports risk-adjusted advancement decisions by providing mechanistic insight into antigen presentation.
- Enables preclinical modeling of adaptive immune responses for immunomodulatory strategies.
Pipeline & Workflow Integration
This method integrates into the discovery continuum from early mechanistic studies to preclinical immunology research, supporting both target validation and assay readiness.
- Discovery Biology: Provides a platform for hypothesis testing of B cell activation and immune synapse dynamics.
- Screening: Delivers standardized, reproducible outputs for quantitative assessment of antigen processing.
- Analytics: Enables measurement of organelle movement, antigen internalization, and MHC presentation for comparative analysis.
- Translational Research: Bridges mechanistic discovery with preclinical immune function studies.
- Enterprise Reuse: Offers a reusable assay system for diverse immunology and cell biology programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic uncertainty in immune pathway studies.
- Operational Value: Standardizes B cell activation protocols for reproducibility and scalability.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency in immunology portfolios.
- Portfolio Impact: Supports risk-adjusted prioritization of immunotherapeutic targets and modalities.
Implementation Considerations
- Requires expertise in immunology, cell culture, and microscopy-based analysis.
- Needs access to antigen-coating reagents, coverslip preparation tools, and imaging infrastructure.
- Demands cross-team standardization for assay reproducibility and data comparability.
- Adaptable to various antigen and antibody systems for broader application.
- Limited to in vitro modeling; in vivo validation may be required for translational claims.
Biopharma FAQs
Why does null hypothesis testing matter for B cell activation assays?
Null hypothesis testing in B cell activation assays ensures that observed immune synapse formation and antigen processing are statistically significant, supporting robust target validation. This reduces the risk of false positives in early discovery. Reliable statistical analysis underpins confidence in mechanistic findings for portfolio decisions.
How does independent variable isolation fit the antigen-coated coverslip workflow?
Isolating variables such as antigen type or antibody concentration on coverslips allows precise attribution of B cell activation outcomes to specific experimental factors. This supports mechanistic de-risking and informs assay optimization. Controlled variable manipulation enhances reproducibility and interpretability for R&D teams.
What do quantitative measurements of antigen internalization enable?
Quantitative assessment of antigen internalization provides objective metrics for comparing B cell activation across conditions or compounds. These measurements enable data-driven screening and facilitate benchmarking of immunomodulatory interventions. Such outputs are critical for advancing candidates through the discovery pipeline.
Why are replication requirements important for immune synapse studies?
Replication ensures that findings on cytoskeletal remodeling and antigen presentation are consistent and generalizable across experiments and teams. This is essential for cross-functional collaboration and for building confidence in assay outputs. Standardized replication supports enterprise-wide adoption of the workflow.
What statistical analysis capabilities are required before implementing B cell activation assays?
Robust statistical tools are needed to analyze organelle dynamics, antigen internalization, and MHC presentation data from B cell activation assays. These capabilities enable teams to distinguish true biological effects from experimental noise. Proper analysis is foundational for informed decision-making in immunology R&D.
10:26
In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Related Videos
0 Views
08:25
Flow Cytometric Characterization of Murine B Cell Development
Related Videos
0 Views
12:46
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Related Videos
0 Views
04:05
CTC Immunofluorescence Assay : A Technique to Characterize Circulating Tumor Cells
Related Videos
0 Views
03:24
Organelle Dynamics in B Lymphocytes following Activation with Antigen-Coated Beads
Related Videos
0 Views
05:29
An In Vitro Technique to Study T Cell Interaction with Supported Planar Lipid Bilayers
Related Videos
0 Views
03:54
Monitoring B Cell Activation with Antigenic Liposomes using a Calcium-Flux Assay
Related Videos
0 Views
04:54
Evaluation of Controlled T Cell Activation with a Photoactivatable Peptide MHC
Related Videos
0 Views
10:31
Real-time Live Imaging of T-cell Signaling Complex Formation
Related Videos
0 Views
07:48
Spatial and Temporal Control of T Cell Activation Using a Photoactivatable Agonist
Related Videos
0 Views
Last updated: 1 August 2026